Lipidomics Services Market size was valued at USD 50 million in 2021, growing at a significant CAGR of 8.0% over 2022–2028. Many lipidomics players have been concentrating on developing new products and biomarker discovery. Burgeoning biomarker discovery is expected to create demand for lipidomics services. Key players focused on adopting innovative MS-based technologies, which helped drive a remarkable transformation in clinical research and biomarker discovery. For example, in June 2017, ProSciento, Inc. and OWL Metabolomics inked an exclusive, multi-year collaboration to establish a database of prospective clinical study participants evaluated for the presence of NAFLD and NASH using OWL’s non-invasive, lipidomics-based diagnostic assay. In addition, the increase in the prevalence of chronic diseases and outbreaks such as the Zika virus infection in Latin America and Oceania are expected to offer enormous opportunities for lipidomics players over the forecast period. Furthermore, academic and research institutes accounted for the largest revenue share in the global market, which is attributed to raising funds from public and private sectors for R&D activities and low service costs compared with industries for lipid analysis. Technological advancements in mass spectrometry and chromatography have greatly improved the development and applications of metabolic profiling of diverse lipids in complex biological samples. For instance, novel approaches based on HPLC-ESI-MS/MS permit the quantitation of complex lipid mixtures, and novel approaches based on MALDI-MS imaging allow the imaging of lipid profiles in tissue sections. The high structural diversity and complex nature of lipid molecules is a severe challenge in lipidomics research. For instance, eukaryotic cells provide an excellent example of the structural complexity of lipids. The complete identification of all types of lipids in lipid extracts obtained from cell or tissue samples has not yet been accomplished due to the extraordinary structural diversity of phospholipids.
Recent Market Developments:
In April 2022, European drug discovery services firm Symeres has acquired U.S. lipid maker and organic chemistry contractor Organix, to enter lipids market and grow in the US.
In February 2018, The Biomolecular Sciences Institute (BSI) and PREMIER Biosoft entered into a research collaboration to provide advanced mass spectrometry-based data analysis solutions for lipidomics.
There are no reviews yet.